Ignite Creation Date:
2024-05-06 @ 3:20 PM
Last Modification Date:
2024-10-26 @ 1:48 PM
Study NCT ID:
NCT04603872
Status:
RECRUITING
Last Update Posted:
2020-10-28
First Post:
2020-10-21
Brief Title:
CAR-T Cells Combined With Dasatinib for Patients With Relapsed andor Refractory B-cell Hematological Malignancies
Sponsor:
Zhejiang University
Organization:
Zhejiang University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non-Hodgkins Lymphoma Refractory |
| Multiple Myeloma in Relapse |
| Multiple Myeloma Refractory |
| Acute Lymphoblastic Leukemia in Relapse |
| Acute Lymphocytic Leukaemia Refractory |
| Non-Hodgkins Lymphoma Relapsed |